China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

The technical challenges and election year posturing facing biotech ETFs belies what some believe is still a bullish long-term investment thesis. The improved outlook for the health care industry ...

The SPDR S&P Biotech ETF (XBI), one of the largest biotech ... That fundamental news helped XBI clear some important technical hurdles, including rallying above its 200-day moving average.

The fund currently labors below $229, though other technical analysts have said if iBB can clear resistance at $235, it could run back to $255. [More Upside Possible for Biotech ETF] “Note that ...

seeks investment results that correlate to the price and yield performance of the NASDAQ Biotechnology Index. In this article I will focus on short term technical outlook for both the IBB ...

SPRINGFIELD - At a time when biotechnology jobs are hitting an all-time high in Massachusetts, Springfield Technical Community College has begun offering one of the few degree-granting ...

IBB), the largest biotechnology exchange traded fund, is facing some critical technical resistance that could determine the ETF's near-term fate. After rallying late in the first quarter and to ...